系统性硬化症患者单核细胞的三种不同转录谱与疾病活动度相关
研究从早期系统性硬化症前瞻性登记队列招募患者,对循环经典单核细胞(CMs)和非经典单核细胞(NCMs)行RNA测序,依据CMs转录特征无偏聚类将患者分为A-C三组,三组在NCMs中保持各自特征;B组和C组肺功能较A组更差,基线皮肤病变无差异;在已发表单核细胞RNA-seq数据中验证,无皮肤病变患者最可能归为A组。
要点
- 依据经典单核细胞转录特征可将系统性硬化症患者无偏分为A、B、C三组。
- B组和C组肺功能较A组更差,基线皮肤病变与对照组无差异。
- 在已发表数据中验证,无皮肤病变患者最可能归为A组。
核心结论
- 首次表明经典单核细胞和非经典单核细胞的转录特征可用于无偏地对系统性硬化症患者分层,并与疾病活动度结局指标相关。
研究设计与样本
- 患者来自早期系统性硬化症前瞻性登记队列,采集临床数据及外周血分离经典单核细胞和非经典单核细胞,并招募年龄、性别和种族匹配的健康志愿者作为对照。
- 另从独立队列的皮肤中分离巨噬细胞,所有样本均行RNA测序。
主要发现
- 基于经典单核细胞相对对照的转录特征,采用无偏方法将患者聚类为A、B、C三组,每组在非经典单核细胞中保持其特有的转录特征。
- C组上调基因在系统性硬化症皮肤巨噬细胞中相对对照的表达高于其他组。
- B组和C组患者肺功能较A组更差,而基线时系统性硬化症皮肤病变相对对照无差异。
- 将分组分类应用于已发表的系统性硬化症患者单核细胞RNA-seq数据,无皮肤病变患者最可能被归为A组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular composition that drive gene expression and an inability to detect minority cell populations. We undertook this study to focus on the 2 main subtypes of circulating monocytes, classical monocytes (CMs) and nonclassical monocytes (NCMs) as a biomarker of SSc disease severity. METHODS: SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-matched healthy volunteers were recruited as controls. Bulk macrophages were isolated from the skin in a separate cohort. All samples were assayed by RNA sequencing (RNA-seq). RESULTS: We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptional signature in NCMs. Genes up-regulated in group C demonstrated the highest expression compared to the other groups in SSc skin macrophages, relative to controls. Patients from groups B and C exhibited worse lung function than group A, although there was no difference in SSc skin disease at baseline, relative to controls. We validated our approach by applying our group classifications to published bulk monocyte RNA-seq data from SSc patients, and we found that patients without skin disease were most likely to be classified as group A. CONCLUSION: We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures.
引用
- Makinde HM, Dunn JLM, Gadhvi G, et al. Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients. Arthritis Rheumatol. 2023. PMID: 36281773. doi:10.1002/art.42380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。